Artwork

Content provided by MDedge and Medscape Professional Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MDedge and Medscape Professional Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Gene testing for all breast cancer patients with second primary malignancy, atezolizumab for TNBC, pralsetinib for NSCLC, and more

11:57
 
Share
 

Manage episode 272090500 series 2608031
Content provided by MDedge and Medscape Professional Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MDedge and Medscape Professional Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Hematology/Oncology News:

  1. Study supports multigene panel testing for all breast cancer patients with second primary cancers: https://bit.ly/3m6RyOGSource: https://bit.ly/2ZKXund

  2. Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 results: https://bit.ly/35rqzrl Alert: https://bit.ly/2Reh1HMTrial: https://bit.ly/2ZqqIqX

  3. Pralsetinib: Second drug for RET+ NSCLC approved in U.S.: https://bit.ly/3bTdGaz

  4. Unexpected results in new COVID-19 ‘cytokine storm’ data: https://bit.ly/3k8fIGL JAMA research letter: https://bit.ly/35ubxB4

You can email the show at podcasts@mdedge.com

  continue reading

100 episodes

Artwork
iconShare
 
Manage episode 272090500 series 2608031
Content provided by MDedge and Medscape Professional Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MDedge and Medscape Professional Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Hematology/Oncology News:

  1. Study supports multigene panel testing for all breast cancer patients with second primary cancers: https://bit.ly/3m6RyOGSource: https://bit.ly/2ZKXund

  2. Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 results: https://bit.ly/35rqzrl Alert: https://bit.ly/2Reh1HMTrial: https://bit.ly/2ZqqIqX

  3. Pralsetinib: Second drug for RET+ NSCLC approved in U.S.: https://bit.ly/3bTdGaz

  4. Unexpected results in new COVID-19 ‘cytokine storm’ data: https://bit.ly/3k8fIGL JAMA research letter: https://bit.ly/35ubxB4

You can email the show at podcasts@mdedge.com

  continue reading

100 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide